Suppr超能文献

四肢骨骼转移性骨病的外科治疗:一项基于人群的研究。

Surgical Treatment of Metastatic Bone Disease in the Appendicular Skeleton: A Population-Based Study.

作者信息

Ladegaard Thea Hovgaard, Sørensen Celine Lykke, Nielsen Rasmus, Troelsen Anders, Al-Mousawi Dhergam Ahmed Ali, Bielefeldt Rikke, Petersen Michael Mørk, Sørensen Michala Skovlund

机构信息

Musculoskeletal Tumor Section, Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, Inge Lehmanns Vej 6, 2100 Copenhagen, Denmark.

Department of Orthopedic Surgery, Herlev and Gentofte Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark.

出版信息

Cancers (Basel). 2022 Feb 28;14(5):1258. doi: 10.3390/cancers14051258.

Abstract

Background: Population-based studies of patients with bone metastases in the appendicular skeleton (aBM) requiring surgery for complete or impending fracture are rare. In this epidemiologically-based observational study we created a large population-based cohort of patients treated for aBM, aiming to: (1) monitor possible time-related changes of the incidence of surgical treatment of aBM-lesions, (2) examine differences in the population and care of patients treated at different treatment centers and (3) examine if findings from a previous pilot study regarding absence of a suitable biopsy of the lesions representing debut of cancer or a relapse has improved the awareness of aBM and hereby increased the focus on regular tumor biopsies and follow-up imaging of cancer patients. Methods: We examined a population-based cohort consisting of all patients treated for aBM 2014−2019. Procedures were performed at five secondary surgical centers (SSC) or one tertiary referral Musculoskeletal Tumor Center (MTC). Patients were followed until end of study (30 September 2021) or death. No patients were lost to follow-up. Results: Four-hundred-fifty-seven patients (493 primary aBM-lesions, 482 procedures) were included. Annual incidence of aBM-surgery was 46 aBM-lesions/million. MTC-patients had a significant better preoperative status than SSC-patients considering factors known for survival. Patients with complete fracture experienced longer surgical delay when treated at MTC compared to SSC: 4 (1−9) and 1 (1−3) days (p < 0.001), respectively. Overall survival for the entire cohort was 37% and 11% at 1 and 5 years (MTC and SSC 1 and 5 year respectively: 44% and 15% vs. 29% and 5%, p < 0.001). In patients with debut or relapse of cancer, 8% and 9% had insufficient biopsies, and 21% and 12% had no biopsy, respectively. Comparison showed no change over time. Conclusions: The current study highlights the low awareness on treating aBM at SSC and emphasizes the importance of caution in interpretation of studies not representing an entire population, thus introducing selection bias.

摘要

背景

针对需要手术治疗完全性或即将发生骨折的四肢骨骼骨转移瘤(aBM)患者开展基于人群的研究较为罕见。在这项基于流行病学的观察性研究中,我们创建了一个大型的基于人群的aBM治疗患者队列,旨在:(1)监测aBM病变手术治疗发生率可能随时间的变化;(2)研究在不同治疗中心接受治疗的患者在人群和护理方面的差异;(3)检查先前一项关于缺乏代表癌症初次发作或复发的病变的合适活检的初步研究结果是否提高了对aBM的认识,从而增加了对癌症患者常规肿瘤活检和后续影像学检查的关注。方法:我们检查了一个基于人群的队列,该队列由2014 - 2019年接受aBM治疗的所有患者组成。手术在五个二级外科中心(SSC)或一个三级转诊肌肉骨骼肿瘤中心(MTC)进行。对患者进行随访直至研究结束(2021年9月30日)或死亡。没有患者失访。结果:纳入了457例患者(493个原发性aBM病变,482例手术)。aBM手术的年发生率为每百万46个aBM病变。考虑到已知的生存因素,MTC患者的术前状况明显优于SSC患者。与SSC相比,MTC治疗的完全骨折患者手术延迟时间更长:分别为4(1 - 9)天和1(1 - 3)天(p < 0.001)。整个队列1年和5年的总生存率分别为37%和11%(MTC和SSC的1年和5年生存率分别为44%和15%,29%和5%,p < 0.001)。在癌症初次发作或复发的患者中,分别有8%和9%的患者活检不足,21%和12%的患者未进行活检。比较显示随时间无变化。结论:当前研究突出了SSC对aBM治疗的认识不足,并强调在解释不代表整个人群的研究时要谨慎,因为这会引入选择偏倚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/8909164/561b25fe97d7/cancers-14-01258-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验